Co-located with the 7th Annual Proteins & Antibodies Congress & the Peptides Congress Oxford Global are proud to present the Biosimilars & Biobetters Congress, taking place on 3-4 April 2014 at Novotel London West, UK.
Over 400 delegates representing leading biotech companies, global pharma organisations and internationally renowned academic institutions
25 presentations, case studies and panel discussions focused on the key issues in follow-on biologics development and commercialisation
2 interactive streams:
Market Opportunities and Commercial Challenges
Developing Biosimilars and Biobetters
14 pre-scheduled one to one meetings, exhibition and informal networking opportunities
The follow on biologics industry is forecast to reach $8.8 billion by 2017. Our conference programme focuses on the challenges, innovations and technologies that promise to put this sector at the forefront of the pharmaceutical industry.
The 2nd Annual Biosimilars and Biobetters Congress features two streams:
Market Opportunities & Commercial Challenges: In Stream 1, the meeting will address the most pressing challenges in gaining access to emerging markets and branding biosimilars through a series of cutting-edge conference presentations. Our boisimilars experts will also debate how to overcome regulatory challenges, outsource manufacturing and develop pricing strategies
Developing Biosimilars & Biobetters: Learn more about current developments in clinical trials, including pharmacovigilence and patient safety. Do not miss out on the chance to discover innovative solutions for achieving quality by design, demonstrating biosimilarity and addressing potency as well as the latest insights into the regulatory requirements and trial design.
The Biosimilars & Biobetters Congress is part of the highly successful Oxford Global Proteins Series.
For more information or to book a place please visit; http://www.biosimilars-congress.com/download-agenda-marketing or contact email@example.com